EdgarLookup

UDR, Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that UDR, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
22.1%
Profit Margin
Net income ÷ revenue
3.6%
Return on Assets
Net income ÷ assets
1.96x
Debt-to-Equity
Total liabilities ÷ equity
+2.4%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.71B Feb 17, 2026
FY2025 Dec 31, 2024 $1.67B Feb 17, 2026
FY2025 Dec 31, 2023 $1.63B Feb 17, 2026
FY2024 Dec 31, 2022 $1.52B Feb 18, 2025
FY2023 Dec 31, 2021 $1.29B Feb 20, 2024
FY2022 Dec 31, 2020 $1.24B Feb 13, 2023
FY2021 Dec 31, 2019 $1.15B Feb 15, 2022
FY2020 Dec 31, 2018 $1.05B Feb 18, 2021
FY2019 Dec 31, 2017 $995.79M Feb 18, 2020
FY2018 Dec 31, 2016 $959.86M Feb 19, 2019

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $11.36M Feb 17, 2026
FY2025 Dec 31, 2024 $8.32M Feb 17, 2026
FY2025 Dec 31, 2023 $6.84M Feb 17, 2026
FY2024 Dec 31, 2022 $5.02M Feb 18, 2025
FY2023 Dec 31, 2021 $6.10M Feb 20, 2024
FY2022 Dec 31, 2020 $5.07M Feb 13, 2023
FY2021 Dec 31, 2019 $14.06M Feb 15, 2022
FY2020 Dec 31, 2018 $11.75M Feb 18, 2021
FY2019 Dec 31, 2017 $11.48M Feb 18, 2020
FY2018 Dec 31, 2016 $11.40M Feb 19, 2019

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $377.70M Feb 17, 2026
FY2025 Dec 31, 2024 $89.59M Feb 17, 2026
FY2025 Dec 31, 2023 $444.35M Feb 17, 2026
FY2024 Dec 31, 2022 $86.92M Feb 18, 2025
FY2023 Dec 31, 2021 $150.02M Feb 20, 2024
FY2022 Dec 31, 2020 $64.27M Feb 13, 2023
FY2021 Dec 31, 2019 $184.97M Feb 15, 2022
FY2020 Dec 31, 2018 $203.11M Feb 18, 2021
FY2019 Dec 31, 2017 $121.56M Feb 18, 2020
FY2018 Dec 31, 2016 $292.72M Feb 19, 2019

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $553.61M Feb 17, 2026
FY2025 Dec 31, 2024 $284.57M Feb 17, 2026
FY2025 Dec 31, 2023 $635.01M Feb 17, 2026
FY2024 Dec 31, 2022 $250.81M Feb 18, 2025
FY2023 Dec 31, 2021 $267.97M Feb 20, 2024
FY2022 Dec 31, 2020 $249.10M Feb 13, 2023
FY2021 Dec 31, 2019 $221.06M Feb 15, 2022
FY2020 Dec 31, 2018 $354.72M Feb 18, 2021
FY2019 Dec 31, 2017 $227.90M Feb 18, 2020
FY2018 Dec 31, 2016 $400.82M Feb 19, 2019

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $902.89M Feb 17, 2026
FY2025 Dec 31, 2024 $876.85M Feb 17, 2026
FY2025 Dec 31, 2023 $832.66M Feb 17, 2026
FY2024 Dec 31, 2022 $820.07M Feb 18, 2025
FY2023 Dec 31, 2021 $663.96M Feb 20, 2024
FY2022 Dec 31, 2020 $604.32M Feb 13, 2023
FY2021 Dec 31, 2019 $630.70M Feb 15, 2022
FY2020 Dec 31, 2018 $560.68M Feb 18, 2021
FY2019 Dec 31, 2017 $518.92M Feb 18, 2020
FY2018 Dec 31, 2016 $536.57M Feb 19, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $10.61B Feb 17, 2026
FY2025 Dec 31, 2024 $10.90B Feb 17, 2026
FY2024 Dec 31, 2023 $11.37B Feb 18, 2025
FY2023 Dec 31, 2022 $11.04B Feb 20, 2024
FY2022 Dec 31, 2021 $10.78B Feb 13, 2023
FY2021 Dec 31, 2020 $9.64B Feb 15, 2022
FY2020 Dec 31, 2019 $9.64B Feb 18, 2021
FY2019 Dec 31, 2018 $7.71B Feb 18, 2020
FY2018 Dec 31, 2017 $7.73B Feb 19, 2019
FY2017 Dec 31, 2016 $7.68B Feb 20, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $6.46B Feb 17, 2026
FY2025 Dec 31, 2024 $6.44B Feb 17, 2026
FY2024 Dec 31, 2023 $6.42B Feb 18, 2025
FY2023 Dec 31, 2022 $6.10B Feb 20, 2024
FY2022 Dec 31, 2021 $6.00B Feb 13, 2023
FY2021 Dec 31, 2020 $5.52B Feb 15, 2022
FY2020 Dec 31, 2019 $5.23B Feb 18, 2021
FY2019 Dec 31, 2018 $3.82B Feb 18, 2020
FY2018 Dec 31, 2017 $3.95B Feb 19, 2019
FY2017 Dec 31, 2016 $3.67B Feb 20, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.29B Feb 17, 2026
FY2025 Dec 31, 2024 $3.44B Feb 17, 2026
FY2024 Dec 31, 2023 $3.99B Feb 18, 2025
FY2023 Dec 31, 2022 $4.10B Feb 20, 2024
FY2022 Dec 31, 2021 $3.44B Feb 13, 2023
FY2021 Dec 31, 2020 $3.23B Feb 15, 2022
FY2020 Dec 31, 2019 $3.36B Feb 18, 2021
FY2019 Dec 31, 2018 $2.91B Feb 18, 2020
FY2018 Dec 31, 2017 $2.83B Feb 19, 2019
FY2017 Dec 31, 2016 $3.09B Feb 20, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.22M Feb 17, 2026
FY2025 Dec 31, 2024 $1.33M Feb 17, 2026
FY2025 Dec 31, 2023 $2.92M Feb 17, 2026
FY2025 Dec 31, 2022 $1.19M Feb 17, 2026
FY2024 Dec 31, 2021 $967.0K Feb 18, 2025
FY2023 Dec 31, 2020 $1.41M Feb 20, 2024
FY2022 Dec 31, 2019 $8.11M Feb 13, 2023
FY2021 Dec 31, 2018 $185.22M Feb 15, 2022
FY2020 Dec 31, 2017 $2.04M Feb 18, 2021
FY2019 Dec 31, 2016 $2.11M Feb 18, 2020

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.82B Feb 17, 2026
FY2025 Dec 31, 2024 $5.83B Feb 17, 2026
FY2024 Dec 31, 2023 $5.80B Feb 18, 2025
FY2023 Dec 31, 2022 $5.49B Feb 20, 2024
FY2022 Dec 31, 2021 $5.41B Feb 13, 2023
FY2021 Dec 31, 2020 $4.98B Feb 15, 2022
FY2020 Dec 31, 2019 $4.71B Feb 18, 2021
FY2019 Dec 31, 2018 $3.55B Feb 18, 2020
FY2018 Dec 31, 2017 $3.67B Feb 19, 2019
FY2017 Dec 31, 2016 $3.40B Feb 20, 2018

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Feb 17, 2026
FY2025 Dec 31, 2024 0 Feb 17, 2026
FY2025 Dec 31, 2023 1 Feb 17, 2026
FY2024 Dec 31, 2022 0 Feb 18, 2025
FY2023 Dec 31, 2021 0 Feb 20, 2024
FY2022 Dec 31, 2020 0 Feb 13, 2023
FY2019 Dec 31, 2019 0 Feb 18, 2020
FY2019 Sep 30, 2019 0 Feb 18, 2020
FY2019 Jun 30, 2019 0 Feb 18, 2020
FY2019 Mar 31, 2019 0 Feb 18, 2020

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Feb 17, 2026
FY2025 Dec 31, 2024 0 Feb 17, 2026
FY2025 Dec 31, 2023 1 Feb 17, 2026
FY2024 Dec 31, 2022 0 Feb 18, 2025
FY2023 Dec 31, 2021 0 Feb 20, 2024
FY2022 Dec 31, 2020 0 Feb 13, 2023
FY2019 Dec 31, 2019 0 Feb 18, 2020
FY2019 Sep 30, 2019 0 Feb 18, 2020
FY2019 Jun 30, 2019 0 Feb 18, 2020
FY2019 Mar 31, 2019 0 Feb 18, 2020

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 328.27M Feb 17, 2026
FY2025 Dec 31, 2024 330.86M Feb 17, 2026
FY2024 Dec 31, 2023 329.01M Feb 18, 2025
FY2023 Dec 31, 2022 328.99M Feb 20, 2024
FY2022 Dec 31, 2021 318.15M Feb 13, 2023
FY2021 Dec 31, 2020 296.61M Feb 15, 2022
FY2020 Dec 31, 2019 294.59M Feb 18, 2021
FY2019 Dec 31, 2018 275.55M Feb 18, 2020
FY2018 Dec 31, 2017 267.82M Feb 19, 2019
FY2017 Dec 31, 2016 267.26M Feb 20, 2018

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $567.86M Feb 17, 2026
FY2025 Dec 31, 2024 $558.48M Feb 17, 2026
FY2025 Dec 31, 2023 $539.85M Feb 17, 2026
FY2024 Dec 31, 2022 $483.62M Feb 18, 2025
FY2023 Dec 31, 2021 $433.78M Feb 20, 2024
FY2022 Dec 31, 2020 $419.35M Feb 13, 2023
FY2021 Dec 31, 2019 $383.08M Feb 15, 2022
FY2020 Dec 31, 2018 $342.24M Feb 18, 2021
FY2019 Dec 31, 2017 $327.79M Feb 18, 2020
FY2018 Dec 31, 2016 $308.92M Feb 19, 2019